Clinical trial • Phase II • Oncology

DS-1062a for Non-small cell lung cancer

Phase II trial of DS-1062a for Non-small cell lung cancer. open-label, none/not specified-controlled. 100 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Non-small cell lung cancer
Trial Stage
Phase II
Drug Modality
ADC

Key dates

Initial CTIS Submission Date
08-08-2024
First CTIS Authorization Date
20-09-2024

Trial design

open-label, none/not specified-controlled Phase II trial in France.

Open Label
Yes
Comparator
None/Not specified
Target Sample Size
100

Eligibility

Recruits 100 Vulnerable population selected; no details provided on consent or assent in source..

Vulnerable Population
Vulnerable population selected; no details provided on consent or assent in source.

Recruitment

Planned Sample Size
100
Recruitment Window Months
83
Consent Approach
No information on informed consent or assent provided.

Geography

Total Number Of Sites
9
Total Number Of Participants
100

France

Earliest CTIS Part Ii Submission Date
20-08-2024
Latest Decision Or Authorization Date
27-10-2025
Processing Time Days
433
Number Of Sites
9
Number Of Participants
100

Sites

Site Name
Institut Bergonie
Department Name
Oncologie
Contact Person Name
Sophie COUSIN
Contact Person Email
s.cousin@bordeaux.unicancer.fr
Site Name
Institut Gustave Roussy
Department Name
Oncologie
Contact Person Name
David Planchard
Site Name
Hospices Civils De Lyon
Department Name
Oncologie
Contact Person Name
Sébastien Couraud
Contact Person Email
ebastien.couraud@chu-lyon.fr
Site Name
Hôpital Cochin
Department Name
Oncologie
Contact Person Name
marie wislez
Contact Person Email
marie.wislez@aphp.fr
Site Name
Les Hopitaux Universitaires De Strasbourg
Department Name
Oncologie
Contact Person Name
Celine MASCAUX
Site Name
Hopital Tenon
Department Name
Oncologie
Contact Person Name
Jacques Cadranel
Contact Person Email
jacques.cadranel@aphp.fr
Site Name
Centre Francois Baclesse
Department Name
Oncologie
Contact Person Name
RADJ Gervais
Contact Person Email
r.gervais@baclesse.fr
Site Name
Centre Hospitalier Regional Et Universitaire De Brest
Department Name
Oncologie
Contact Person Name
MARGAUX Geier
Contact Person Email
margaux.geier@chu-brest.fr
Site Name
Centre Hospitalier Intercommunal de Créteil
Department Name
Oncologie
Contact Person Name
christos Chouaid
Contact Person Email
christos.chouaid@chicreteil.fr

Sponsor

Primary sponsor

Full Name
Institut Gustave Roussy
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Investigational products

Investigational Product Name
DS-1062a, an Anti-TROP-2-Antibody-Drug Conjugate (ADC)
Active Substance
DS-1062a
Modality
ADC

Related trials

Other published trials that may interest you.